Literature DB >> 3783328

Expiratory flow limitation in infants with bronchopulmonary dysplasia.

R S Tepper, W J Morgan, K Cota, L M Taussig.   

Abstract

We evaluated lung function in 20 infants with bronchopulmonary dysplasia (BPD) during the first year of life. Compared with a group of age- and size-matched controls, the infants with BPD had a significantly (P less than 0.005) lower functional residual capacity (FRC; 25 +/- 4 vs 18 +/- 6 ml/kg) at less than 10 1/2 months after conception, but no significant difference during the remainder of the first year. The partial expiratory flow volume curves in the infants with BPD were markedly concave, with tidal breathing approaching expiratory flow limitation. The infants with BPD had significantly (P less than 0.01) lower absolute and size-corrected flows than did control infants, and 50% of the infants with BPD required rehospitalization because of acute respiratory distress associated with a lower respiratory tract illness. In addition, the slope of the linear regression of maximal expiratory flow at FRC (in milliliters per second) vs length (in centimeters) was significantly lower (P less than 0.001) for the infants with BPD than for normal control infants (2.25 vs 4.52), indicating poor growth of the airways. Oxygen saturation (SaO2 was negatively correlated with maximal expiratory flow at FRC, indicating that measurement of SaO2 alone may not be sufficient in the evaluation of lung function in infants with BPD. We conclude that, although infants with BPD improve clinically during the first year of life, they have abnormal functional airway growth; the decreased expiratory flow reserve helps to explain their high risk for acute respiratory distress during lower respiratory tract illness.

Entities:  

Mesh:

Year:  1986        PMID: 3783328     DOI: 10.1016/s0022-3476(86)80296-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

2.  Assessment of pulmonary function in resolving chronic lung disease of prematurity.

Authors:  R Iles; A T Edmunds
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

3.  Surfactant use based on the oxygenation response to lung recruitment during HFOV in VLBW infants.

Authors:  Pierre Tissières; Patrick Myers; Maurice Beghetti; Michel Berner; Peter C Rimensberger
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

Review 4.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 5.  Influence of infection during pregnancy on fetal development.

Authors:  Kristina M Adams Waldorf; Ryan M McAdams
Journal:  Reproduction       Date:  2013-10-01       Impact factor: 3.906

Review 6.  Particle transport and deposition: basic physics of particle kinetics.

Authors:  Akira Tsuda; Frank S Henry; James P Butler
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

7.  Longitudinal measures of lung function in infants with bronchopulmonary dysplasia.

Authors:  Amy G Filbrun; Antonia P Popova; Marisa J Linn; Nancy A McIntosh; Marc B Hershenson
Journal:  Pediatr Pulmonol       Date:  2010-11-17

8.  Lung function eight years after neonatal ventilation.

Authors:  B Andréasson; M Lindroth; W Mortensson; N W Svenningsen; B Jonson
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

9.  Respiratory illness in families of preterm infants with chronic lung disease.

Authors:  J P de Winter; L van Sonderen; J N van den Anker; I T Merth; R Brand; F van Bel; H M Zonderland; P H Quanjer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

10.  Fetal Origins of Asthma: A Longitudinal Study from Birth to Age 36 Years.

Authors:  Stefano Guerra; Enrico Lombardi; Debra A Stern; Duane L Sherrill; Dorothy Gilbertson-Dahdal; Courtney M Wheatley-Guy; Eric M Snyder; Anne L Wright; Fernando D Martinez; Wayne J Morgan
Journal:  Am J Respir Crit Care Med       Date:  2020-12-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.